Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
32.32
-0.37 (-1.13%)
Feb 21, 2025, 4:00 PM EST - Market closed
Ionis Pharmaceuticals Analyst Ratings
Total Analysts
19
Consensus Rating
Buy
Price Target
$61.24
Upside
+89.48%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $67 → $64 | Strong Buy | Maintains | $67 → $64 | +98.02% | Feb 20, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $70 | Buy | Reiterates | $70 | +116.58% | Feb 20, 2025 |
| BMO Capital | BMO Capital | Hold Maintains $60 → $45 | Hold | Maintains | $60 → $45 | +39.23% | Feb 20, 2025 |
| Needham | Needham | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +85.64% | Feb 20, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $70 | Buy | Reiterates | $70 | +116.58% | Jan 15, 2025 |
| Needham | Needham | Strong Buy Maintains $60 | Strong Buy | Maintains | $60 | +85.64% | Dec 20, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $65 → $62 | Buy | Maintains | $65 → $62 | +91.83% | Nov 14, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $82 → $77 | Buy | Maintains | $82 → $77 | +138.24% | Nov 7, 2024 |
| Needham | Needham | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +85.64% | Nov 7, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $70 → $65 | Strong Buy | Maintains | $70 → $65 | +101.11% | Oct 9, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $70 | Buy | Reiterates | $70 | +116.58% | Sep 26, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $50 → $55 | Hold | Maintains | $50 → $55 | +70.17% | Aug 26, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $64 → $70 | Strong Buy | Maintains | $64 → $70 | +116.58% | Aug 2, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $33 → $37 | Strong Sell | Maintains | $33 → $37 | +14.48% | Aug 2, 2024 |
| Barclays | Barclays | Hold Maintains $45 → $51 | Hold | Maintains | $45 → $51 | +57.80% | Aug 2, 2024 |
| Needham | Needham | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +85.64% | Aug 2, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.